Atlanta Consulting Group Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-931
Closed -$326K 150
2025
Q4
$326K Buy
+931
New +$315K 0.07% 125

Other funds holding ELV

Atlanta Consulting Group Advisors's ELV Position: Q1 2026 in Review

Atlanta Consulting Group Advisors sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 931 shares — an estimated $326K sold.

Atlanta Consulting Group Advisors first reported a position in ELV in Q4 2025 and held it in 1 quarter. The position peaked at $326K in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Atlanta Consulting Group Advisors reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Atlanta Consulting Group Advisors sold 931 Elevance Health shares in Q1 2026, an estimated $326K.
  • Atlanta Consulting Group Advisors first reported a position in Elevance Health in Q4 2025 and held it in 1 quarter.
  • Atlanta Consulting Group Advisors's Elevance Health position peaked at $326K in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Atlanta Consulting Group Advisors's 13F filing for Q1 2026, filed 15 May 2026.